Research News
Dr. Alejandro Villagra has received a new NIH R01 grant entitled "Development of selective HDAC6 inhibitors to improve cancer immunotherapy”, with a total funding amount of $3,024,000 for five years. The objective of this grant is to develop and...
This research in Briefings in Bioinformatics identifies mutational hotspots in non-coding regions from multiple cancers through whole genome sequence analysis. J P Torcivia, R Mazumder. Briefings in Bioinformatics, bbaa203, ...
HDAC6 plays a non-canonical role in the regulation of anti-tumor immune responses, dissemination, and invasiveness of breast cancer.
BGL3 lncRNA mediates retention of the BRCA1/BARD1 complex at DNA damage site.
Hu Z, Mi S, Zhao T, Peng C, Peng Y, Chen L, Zhu W, Yao Y, Song Q, Li X, Li X, Jia C, Pei H. EMBO J. 2020 Apr 29:e104133. doi: 10.15252/embj.2019104133.
This research, published in Cell Stem Cell defines how skin resident adipocytes contribute to macrophage inflammation after injury and change their...
